Condition
General Cancer Care and Prevention
Cancer is a group of diseases in which cells ignore signals to stop dividing or die, multiplying unchecked and sometimes spreading. Vitamin D and omega-3 fatty acids carry the strongest evidence, rated moderate, and smaller studies found lower colorectal cancer risk with Korean ginseng and better immune measures with reishi. The ginseng and reishi findings are limited, and vitamin E and beta-carotene showed no clear benefit.
Sources: PMID 16428086
- Supplements studied
- 13
- Medicines and peptides
- 1
- Graded outcomes
- 10
- Trials
- 20
- People studied
- 1,075,857
Evidence by supplement
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anxiety Symptoms Large Improvement | Improves (the measure goes down) | Large effect | 128 people | |||
| Stress Signs and Symptoms | Improves (the measure goes down) | 1 study | 177 people | |||
Studies that measured stress signs and symptoms | ||||||
| Depression Symptoms | Improves (the measure goes down) | 304 people | ||||
Reishi
- Immunity: improves
- Natural Killer Cell Activity: improves
- TNF-Alpha: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Immunity Small Improvement | Improves (the measure goes up) | Small effect | 3 studies | 34 people | ||
Studies that measured immunity
| ||||||
| Natural Killer Cell Activity | Improves (the measure goes up) | 34 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 34 people | ||||
Spirulina
- CD4 Lymphocytes: worsens
- White Blood Cell Count: improves
- CD8 Lymphocytes: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| CD4 Lymphocytes Small Decrease | Worsens (the measure goes down) | Small effect | 100 people | |||
| White Blood Cell Count | Improves (the measure goes up) | 1 study | 100 people | |||
Studies that measured white blood cell count | ||||||
| CD8 Lymphocytes | Improves (the measure goes up) | 100 people | ||||
| Complement Component 4 | Improves (the measure goes up) | 100 people | ||||
| Hemoglobin | Improves (the measure goes up) | 100 people | ||||
| Immunoglobulin A | Improves (the measure goes up) | 100 people | ||||
| Immunoglobulin G | Improves (the measure goes up) | 100 people | ||||
| Immunoglobulin M | Improves (the measure goes up) | 100 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 100 people | ||||
| Serum Platelets | Improves (the measure goes up) | 100 people | ||||
Panax Ginseng (Korean Ginseng)
- Colorectal Cancer Risk: improves
- Overall Cancer Risk: changes; see studies
- Ovarian Cancer Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Colorectal Cancer Risk Moderate Improvement | Improves (the measure goes down) | Moderate effect | 3,974 people | |||
| Overall Cancer Risk | Changes; see studies | 2 studies | 4,617 people | |||
| Ovarian Cancer Risk | Changes; see studies | 3,974 people | ||||
| Pancreatic Cancer Risk | Changes; see studies | 3,974 people | ||||
Vitamin E
- All-Cause Mortality
- Prostate Cancer Risk: improves
- Stroke Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| All-Cause Mortality No effect | NoneNo effect | 2 studies | 89,293 people | |||
| Prostate Cancer Risk | Improves (the measure goes down) | 4 studies | 45,074 people | |||
Studies that measured prostate cancer risk
| ||||||
| Stroke Risk | Changes; see studies | 2 studies | 89,293 people | |||
| Cardiovascular Disease Mortality | Improves (the measure goes down) | 1 study | 89,293 people | |||
Studies that measured cardiovascular disease mortality | ||||||
| Breast Cancer Risk | Changes; see studies | 89,293 people | ||||
| Cancer Mortality | Improves (the measure goes down) | 49,417 people | ||||
| Colorectal Cancer Risk | Improves (the measure goes down) | 89,293 people | ||||
| Esophageal Cancer Risk | Changes; see studies | 9,541 people | ||||
| Heart Failure Risk | Changes; see studies | 9,541 people | ||||
| Lung Cancer Risk | Changes; see studies | 49,417 people | ||||
| Major Adverse Cardiac Events | Changes; see studies | 9,541 people | ||||
| Melanoma Risk | Changes; see studies | 9,541 people | ||||
| Risk Of Cardiovascular Disease | Improves (the measure goes down) | 39,876 people | ||||
Whey Protein
- Length of hospitalization
- Strength: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Length of hospitalization No effect | NoneNo effect | 1 study | 657 people | |||
Studies that measured length of hospitalization | ||||||
| Strength | Improves (the measure goes up) | 2 studies | 657 people | |||
Studies that measured strength | ||||||
Beta-Carotene
- Overall Cancer Risk
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Overall Cancer Risk No benefit in 12-year Physicians' Health Study (50mg every other day) in non-smokers | NoneNo effect | 50,000 people |
Zinc
- Dysgeusia: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Dysgeusia | Improves (the measure goes up) | 2 studies | 58 people | |||
Senna
- Constipation Signs and Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Constipation Signs and Symptoms | Improves (the measure goes down) | 2 studies | 91 people | |||
S-adenosylmethionine
- Liver Enzymes: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Liver Enzymes | Changes; see studies | 1 study | 50 people | |||
Studies that measured liver enzymes | ||||||
Ginkgo Biloba
- Overall Cancer Risk: changes; see studies
- Breast Cancer Risk: worsens
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Overall Cancer Risk | Changes; see studies | 1 study | 3,069 people | |||
Studies that measured overall cancer risk | ||||||
| Breast Cancer Risk Small Detriment | Worsens (the measure goes up) | Small effect | 3,069 people | |||
Melatonin
- Cancer Mortality: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cancer Mortality | Improves (the measure goes down) | 1 study | 643 people |
Prescription medicines and peptides studied, for context
Thymosin Alpha-1
- Overall Survival (Adjuvant): improves
- Chemotherapy Tolerance: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Overall Survival (Adjuvant) Small Improvement | Improves (the measure goes up) | Small effect | 6 studies | 720 people | ||
| Chemotherapy Tolerance Moderate Improvement | Improves (the measure goes up) | Moderate effect | 2 studies | 410 people |
Key findings
- Anxiety SymptomsImproves (the measure goes down)
- Analgesic UseImproves (the measure goes down)
- ImmunityImproves (the measure goes up)
The General Cancer Care and Prevention protocol
2 primary supplements · 5 supporting supplements
- Vitamin D2,000–4,000 IU daily (target 40–60 ng/mL)
- Omega-3 Fatty Acids2–4 g EPA/DHA daily
Studies cited
6 studies from PubMed
- Kefir Is a Viable Exercise Recovery Beverage for Cancer Survivors Enrolled in a Structured Exercise Program
- Effects of ketogenic diets on cancer-related variables: A systematic review and meta-analysis of randomised controlled trials.
- Oral nutritional supplementation in cancer patients: A systematic review and dose-response meta-analysis.
- Feasibility and preliminary efficacy of the effects of flavanoid-rich purple grape juice on the vascular health of childhood cancer survivors: a randomized, controlled crossover trial
- Bright light therapy has a positive effect on sleep quality in patients with cancer: A meta-analysis.
- Drinking of maté and the risk of cancers of the upper aerodigestive tract in Latin America: a case-control study